Down-regulation of the expression of rat inhibitor-of-apoptosis protein-1 and -3 during transforming growth factor-β1-mediated apoptosis in rat brain microglia

NeuroReport

Volumn 14, Issue 6, 2003, Pages 857-860

  Jung, Bomi ^a   Kim, Mi Ok ^a   Yun, Su Jin ^a   Lee, Eunjoo H ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Apoptosis; Inhibitor of apoptosis protein; Microglia; Transforming growth factor 1

Indexed keywords

DNA FRAGMENT; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 3; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; MEDIATOR; MICROGLIA; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; DNA FRAGMENTATION; DOWN-REGULATION; INHIBITOR OF APOPTOSIS PROTEINS; MICROGLIA; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0038540335     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200305060-00016     Document Type: Article

References (25)

1. Aloisi F. Glia 36, 165-179 (2001).
2. Bruce-Keller AJ. J Neurosci Res 58, 191-201 (1999).
3. Stoll G and Jander S. Prog Neurobiol 58, 233-247 (1999).
4. Unsicker K, Flanders KC, Cissel DS et al. Neuroscience 44, 613-625 (1991).
5. Bottner M, Krieglstein K and Unsicker K. J Neurochem 75, 2227-2240 (2000).
6. Jones LL, Kreutzberg GW and Raivich G. Brain Res 795, 301-306 (1998).
7. Xiao BG, Zhang GX, Ma CG et al. Clin Exp Immunol 103, 475-482 (1996).
8. Suzumura A, Sawada M, Yamamoto H et al. J Immunol 151, 2150-2158 (1993).
9. Lodge PA and Sriram S. J Leukoc Biol 60, 502-508 (1996).
10. Hu S, Sheng WS, Peterson PK et al. Glia 13, 45-50 (1995).
11. Xiao BG, Bai XF, Zhang GX et al. Neurosci Lett 226, 71-74 (1997).
12. Hengartner MO. Nature 407, 770-776 (2000).
13. Deveraux QL and Reed JC. Genes Dev 13, 239-252 (1999).
14. McCarthy KD and de Vellis J. J Cell Biol 85, 890-902 (1980).
15. Yun SJ, Kim MO, Kim SO et al. Mol Brain Res 107, 57-64 (2002).
16. Holcik M, Lefebvre CA, Hicks K et al. BMC Genomics 3, 5 (2002).
17. Belluardo N, Korhonen L, Mudo G et al. Eur J Neurosci 15, 87-100 (2002).
18. Kiefer R, Streit WJ, Yoykka KV et al. Int J Dev Neurosci 13, 331-339 (1995).
19. Lindholm D, Catren E, Kiefer R et al. J Cell Biol 117, 395-400 (1992).
20. Shrikant P, Lee SJ, Kalvakolanu I et al. J Immunol 157, 892-900 (1996).
21. Park SK, Grzybicki D, Lin HL et al. Neuropharmacol 33, 1419-1423 (1994).
22. Webster JC, Huber RM, Hanson RL et al. Endocrinol 143, 3866-3874 (2002).
23. Park SY, Billiar TR and Seol DW. Biochem Biophys Res Commun 291, 233-236 (2002).
24. Herrera B, Fernandez M, Benito M et al. FEBS Lett 520, 93-96 (2002).
25. Ishigaki S, Liang Y, Yamamoto M et al. J Neurochem 82, 576-584 (2002).